Mosquito-Borne Rift Valley Fever Virus Linked to Miscarriage in Humans
|
By LabMedica International staff writers Posted on 11 Oct 2016 |
|
Image: Proteins from Rift Valley fever virus (Photo courtesy of Medical Xpress).
Rift Valley fever virus (RVFv) has been linked to miscarriage in a cross-sectional study of pregnant Sudanese women with fever, which indicated a 7 times greater risk of miscarriage for infected women.
“In parts of Africa where there are RVF outbreaks, human miscarriages have never been linked to this particular viral infection, until now,” said co-author Magnus Evander, professor at Umeå University Faculty of Medicine (Umeå, Sweden), “With these results, we can add miscarriage to the list of known complications from RVF. This discovery is important for maternal health and for our efforts to develop preventive measures to minimize miscarriages, which are a big health problem for women in the affected areas of Africa.” The study was a collaboration between researchers at Umeå University, the Swedish Defense Research Agency (FOI), and clinicians in Sudan.
RVFv, mostly in Africa and on the Arabian Peninsula, regularly causes large outbreaks with hundreds of thousands of infected people and animals (e.g. cows, sheep, goats). RVF usually produces mild, influenza-like symptoms in humans, but in about 8% of cases, infected people develop serious symptoms, such as liver damage, serious eye infection, internal and external bleeding, meningitis, and death. In animals it often leads to death and as well as pregnancy miscarriages.
The new results are based on a study of 130 pregnant women with fever in Sudan, where outbreaks are a large and recurring health problem. Of the 130 patients, 27 had a miscarriage and 4 had premature births. The women infected with RVFv had a 7 times greater risk of miscarriage.
”Because RVF is caused by a mosquito-borne virus, there is a potential risk of global spread, which has been the case with the Zika virus. The fact that RVF could lead to miscarriage is very worrying,” said Prof. Evander.
The study was published September 27, 2016, in the journal Lancet Global Health.
Related Links:
Umeå University Faculty of Medicine
“In parts of Africa where there are RVF outbreaks, human miscarriages have never been linked to this particular viral infection, until now,” said co-author Magnus Evander, professor at Umeå University Faculty of Medicine (Umeå, Sweden), “With these results, we can add miscarriage to the list of known complications from RVF. This discovery is important for maternal health and for our efforts to develop preventive measures to minimize miscarriages, which are a big health problem for women in the affected areas of Africa.” The study was a collaboration between researchers at Umeå University, the Swedish Defense Research Agency (FOI), and clinicians in Sudan.
RVFv, mostly in Africa and on the Arabian Peninsula, regularly causes large outbreaks with hundreds of thousands of infected people and animals (e.g. cows, sheep, goats). RVF usually produces mild, influenza-like symptoms in humans, but in about 8% of cases, infected people develop serious symptoms, such as liver damage, serious eye infection, internal and external bleeding, meningitis, and death. In animals it often leads to death and as well as pregnancy miscarriages.
The new results are based on a study of 130 pregnant women with fever in Sudan, where outbreaks are a large and recurring health problem. Of the 130 patients, 27 had a miscarriage and 4 had premature births. The women infected with RVFv had a 7 times greater risk of miscarriage.
”Because RVF is caused by a mosquito-borne virus, there is a potential risk of global spread, which has been the case with the Zika virus. The fact that RVF could lead to miscarriage is very worrying,” said Prof. Evander.
The study was published September 27, 2016, in the journal Lancet Global Health.
Related Links:
Umeå University Faculty of Medicine
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Gold Member
Hematology Analyzer
Medonic M32B
Urine Chemistry Control
Dropper Urine Chemistry Control
Latest Microbiology News
- WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
- New Imaging Approach Could Help Predict Dangerous Gut Infection
- Rapid Sequencing Could Transform Tuberculosis Care
- Blood-Based Viral Signature Identified in Crohn’s Disease
- Hidden Gut Viruses Linked to Colorectal Cancer Risk
- Three-Test Panel Launched for Detection of Liver Fluke Infections
- Rapid Test Promises Faster Answers for Drug-Resistant Infections
- CRISPR-Based Technology Neutralizes Antibiotic-Resistant Bacteria
- Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
- AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
- New Test Measures How Effectively Antibiotics Kill Bacteria
- New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
- New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
- Breakthroughs in Microbial Analysis to Enhance Disease Prediction
- Blood-Based Diagnostic Method Could Identify Pediatric LRTIs
- Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Channels
Clinical Chemistry
view channel
AI Sensor Detects Neurological Disorders Using Single Saliva Drop
Neurological disorders such as Parkinson’s disease and Alzheimer’s disease often develop gradually and present subtle symptoms in their early stages. Because early signs are frequently vague or atypical,... Read more
New Blood Test Index Offers Earlier Detection of Liver Scarring
Metabolic fatty liver disease is highly prevalent and often silent, yet it can progress to fibrosis, cirrhosis, and liver failure. Current first-line blood test scores frequently return indeterminate results,... Read more
Molecular Diagnostics
view channel
AI-Powered Blood Test Detects Early Pancreatic Cancer with More Than 90% Accuracy
Pancreatic cancer is one of the most lethal cancers, often referred to as the “King of Cancers” because symptoms usually appear only at advanced stages. As a result, most patients are diagnosed late, and... Read more
AI-Powered Blood Test Flags Relapse Risk Earlier After Transplant
Relapse after allogeneic hematopoietic cell transplant is a major cause of mortality in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and standard monitoring can miss early warning signals.... Read more
World’s First Portable POC Test Simultaneously Detects Four Common STIs in One Hour
Sexually transmitted infections (STIs) often present with similar symptoms, making accurate diagnosis challenging without laboratory testing. Delays in identifying the exact infection can lead to inappropriate... Read more
Hematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Immunology
view channel
Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response
Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more
Immune Signature Identified in Treatment-Resistant Myasthenia Gravis
Myasthenia gravis is a rare autoimmune disorder in which immune attack at the neuromuscular junction causes fluctuating weakness that can impair vision, movement, speech, swallowing, and breathing.... Read more
New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer
Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read morePathology
view channel
Novel mcPCR Technology to Transform Testing of Clinical Samples
DNA methylation is an important biological marker used in the diagnosis and monitoring of many diseases, including cancer. These chemical modifications to DNA influence gene activity and can reveal early... Read more
Sex Differences in Alzheimer’s Biomarkers Linked to Faster Cognitive Decline
Sex differences in Alzheimer’s disease present ongoing diagnostic challenges, with women often experiencing a disproportionate disease burden even when preclinical amyloid-beta levels are similar to men.... Read more
Technology
view channel
AI Model Outperforms Clinicians in Rare Disease Detection
Rare diseases affect an estimated 300 million people worldwide, yet diagnosis is often protracted and error-prone. Many conditions present with heterogeneous signs that overlap with common disorders, leading... Read more
AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
Periprosthetic joint infection (PJI) is a rare but serious complication affecting 1% to 2% of primary joint replacement surgeries. The condition occurs when bacteria or fungi infect tissues around an implanted... Read more
Industry
view channel
Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical
Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more
Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss
Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio
QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
